
Keynote Speakers
Lars Gille, PhD
University of Veterinary Medicine, Vienna (Austria)
Sergi Segarra, PhD
Bioiberica (Spain)
Ingo Schäfer, PhD
Laboklin GmbH & Co. KG, Department of Clinical Pathology, Bad Kissingen, Bavaria (Germany)
Feline leishmaniosis: a practical approach with clinical signs, diagnostics, therapy and management
Albert Descoteaux, PhD
INRS (Canada)
Inter-organelle communication in Leishmania-infected macrophages
Márcia Dalastra Laurenti, PhD
Medical School, University of São Paulo, São Paulo (Brazil)
Non-Ulcerated Cutaneous Leishmaniasis, a Benign Clinical Form of Leishmania (L.) infantum chagasi Infection
Marie Lipoldová, PhD
Charles University in Prague (Czech Republic)
Role of interferon-induced GTPases in leishmaniasis
Carolina Rodriguez-Cariño, PhD
Veterinary Pathologist, Clinical Pathology Department, IDEXX laboratories Iberia, Barcelona (Spain)
Pericardial effusion as a clinical manifestation of canine leishmaniosis
Paul Denny, PhD
Durham University, Durham (UK)
Sanjai Nagendra, MD
Medical Director Center for Esoteric Testing and Atlantic Regional Labs, Burlington (USA)
Ger van Zandbergen, PhD
Federal Institute for Vaccines and Biomedicines, Berlin (Germany)
Parasite and host cell signals driving Leishmania propagation in human macrophages
William Kerr, PhD
Ospedale Policlinico San Martino/SUNY Upstate Medical University, New York (USA)
Inhibition of the SHIP1/2 paralogs to combat infection and disease
Angela Kaysel Cruz, PhD
Laboratório de Parasitologia Molecular, Faculdade de Medicina de Riberão Preto, University of São Paulo, São Paulo (Brazil)
Expanding the landscape of noncoding RNA–mediated gene regulation in Leishmania